Antiphospholipid syndrome
Copyright policy )Antiphospholipid syndrome
This corrects the article DOI: 10.1038/nrdp.2017.103.
- Copenhagen University Hospital Denmark
- Rigshospitalet Denmark
- University of Turin Italy
- University of Copenhagen Denmark
- University of Copenhagen Denmark
Adult, Aspirin, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, Thrombosis, Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; Quality of Life; Risk Assessment; Thrombosis, Antiphospholipid Syndrome, Risk Assessment, Pregnancy Complications, Pregnancy, Antibodies, Antiphospholipid, Quality of Life, Humans, Female
Adult, Aspirin, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, Thrombosis, Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; Quality of Life; Risk Assessment; Thrombosis, Antiphospholipid Syndrome, Risk Assessment, Pregnancy Complications, Pregnancy, Antibodies, Antiphospholipid, Quality of Life, Humans, Female
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).366 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.1%
Citations provided by BIP!Popularity provided by BIP!